Monroe Terilyn J. 4
4 · Guardant Health, Inc. · Filed Jan 16, 2026
Insider Transaction Report
Form 4
Monroe Terilyn J.
Chief People Officer
Transactions
- Exercise/Conversion
Common Stock
2026-01-15+17,379→ 38,369 total - Tax Payment
Common Stock
[F1]2026-01-15$111.98/sh−8,808$986,320→ 29,561 total - Exercise/Conversion
Restricted Stock Units
[F2][F3]2026-01-15−17,379→ 17,379 totalExercise: $0.00→ Common Stock (17,379 underlying)
Footnotes (3)
- [F1]These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
- [F2]This represents a restricted stock unit award granted on February 26, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on the one-year anniversary of January 15, 2024 and the remaining 67% of the shares vest annually over the remaining two-year period, thereafter.
- [F3]Not applicable for Restricted Stock Units.
Signature
/s/ John G. Saia, as attorney-in-fact for Tarilyn J. Monroe|2026-01-16